One of the subsidiaries of Sun Pharmaceutical Industries Ltd, the largest Indian drug maker, has entered into an agreement to acquire US-based InSite Vision Inc. in a deal worth $48 million, the company announced on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
